Loading organizations...
§ Private Profile
Mentor Worldwide, LLC, a Johnson & Johnson Company is a company.
Key people at Mentor Worldwide, LLC, a Johnson & Johnson Company.
Mentor Worldwide, LLC, a Johnson & Johnson Company, develops and manufactures specialized medical devices for breast aesthetics and reconstruction. Its core offerings include advanced breast implants and tissue expanders. The company applies extensive expertise to create solutions for cosmetic enhancement and post-mastectomy reconstructive needs, focusing on patient-centric quality.
Founded in 1969, Mentor initially focused on incontinence products, including a successful disposable catheter in 1974. This early medical device experience provided a foundation for its strategic shift. The company leveraged technological insights to specialize in aesthetic market solutions, evolving its product development to address specific patient demands in this growing field.
Mentor serves patients seeking breast aesthetic and reconstructive procedures, collaborating with healthcare professionals for informed decisions. The company aims to enhance individual confidence through reliable, innovative medical options, emphasizing safety and efficacy. Its vision targets improving patient outcomes with high-quality reconstructive and aesthetic solutions globally, continually advancing care.
Key people at Mentor Worldwide, LLC, a Johnson & Johnson Company.
Mentor Worldwide, LLC, a Johnson & Johnson company, is the global leader in breast implant manufacturing, research, and testing, specializing in silicone gel-filled and saline-filled implants for breast augmentation and reconstruction.[1][2][3][4] Headquartered in Irvine, California, and founded in 1969, it serves patients undergoing surgical procedures—nearly 400,000 annually in the U.S. alone—by providing science-based products that enhance quality of life, while operating in over 117 countries with a focus on safety, innovation, and physician-recognized integrity.[1][2][4] The company addresses key needs in aesthetic and reconstructive surgery, supporting about seven million women worldwide, with products made exclusively in the U.S. and Europe.[1][2]
Mentor Worldwide was founded in 1969 as a pioneer in breast aesthetics, developing, manufacturing, and marketing innovative products for surgical and non-surgical procedures over more than 30 years.[1][2] It built its reputation on rigorous safety standards in manufacturing, testing, and clinical trials for saline and silicone implants.[1] A pivotal moment came with its acquisition by Johnson & Johnson, integrating it into the Johnson & Johnson Family of Companies and amplifying its global reach to over 117 countries while maintaining its Irvine headquarters.[2] Early traction stemmed from consistent physician recognition for product integrity, evolving into the #1 brand in breast aesthetics.[1][2]
Mentor rides the wave of advancing medical devices in aesthetic and reconstructive surgery, fueled by rising demand for personalized breast procedures amid growing awareness of body positivity and post-mastectomy reconstruction.[2][4] Timing aligns with market expansion—supporting seven million women globally—and favorable forces like surgeon preferences for U.S./Europe-made implants and regulatory approvals for innovative textures and expanders.[1][2][4] As part of Johnson & Johnson MedTech, it influences the ecosystem by partnering with innovation hubs like Octane OC, fostering SoCal collaborations, talent access, and expertise to drive patient value and elevate standards in plastic surgery.[2]
Mentor is poised to expand its dominance through continuous innovation in implant technology and supportive programs, capitalizing on trends like personalized medicine, DEI in healthcare, and global demand growth in breast aesthetics.[2][4] Emerging focuses may include next-gen materials for durability and integration with digital surgical planning, strengthening its J&J synergies amid a competitive field (e.g., Sientra, Allergan).[1] Its influence could evolve by deepening ecosystem partnerships, ultimately empowering more patients while solidifying its legacy as the breast implant benchmark.[2]
